About the Authors
- Patrick Vallance
-
* E-mail: patrick.5.vallance@gsk.com
Affiliation President R&D, GlaxoSmithKline, Brentford, Middlesex, United Kingdom
- Andrew Freeman
-
Affiliation Head Medical Policy, GlaxoSmithKline, Brentford, Middlesex, United Kingdom
- Murray Stewart
-
Affiliation Chief Medical Officer GlaxoSmithKline, Collegeville, Pennsylvania, United States of America
Competing Interests
We have read the journal's policy and have the following conflicts: PV is a President at GlaxoSmithKline and holds stock or stock options in GlaxoSmithKline. AF is Head of Medical Policy at GlaxoSmithKline and holds stock or stock options in GlaxoSmithKline. MS is Chief Medical Officer at GlaxoSmithKline and holds stock or stock options in GlaxoSmithKline. PV is a member of the Editorial Board of PLOS Medicine.
Author Contributions
Wrote the first draft of the manuscript: PV AF MS. Contributed to the writing of the manuscript: PV AF MS. Agree with the manuscript’s results and conclusions: PV AF MS. All authors have read, and confirm that they meet, ICMJE criteria for authorship.